Altran Foundation for Innovation

Last updated
Altran Foundation for Innovation
Founded1996
Focus Research
Location
Area served
Global
MethodTechnological Support
Key people
Philippe Salle, President of the Altran Foundation for Innovation, Chairman &Chief Executive of the Altran group; Frédéric Fougerat, Executive Vice-President of the Altran Foundation for Innovation, Group Communications Director; Christian Le Liepvre, Director of the Altran Foundation for Innovation; Corinne Jouanny, Director of Altran Pr[i]me; Jean Audouze, Vice-President of the French National Commission for UNESCO
Website www.altran-foundation.org

The Altran Foundation for Innovation is one of the key vehicles of the societal action of the group Altran Technologies. Created in 1996, its main focus is promoting technological innovation for human benefit. One of the ways it does this is by holding an international scientific competition with a new theme every year, rewarding leaders of innovative technology-oriented projects.

Contents

Health Awards

Brain-powered remote control for paralyzed people

The brain–computer interface system of Professor Jonathan Wolpaw aims to facilitate the communication of patients with locked-in syndrome. It enables patients to move a cursor on a computer screen, dictate a text or control a robotic arm. [1]

Artificial retina

The artificial retina of Professor José Sahel and his team at the Quinze-Vingts National Ophthalmology Hospital Centre aims to allow people with degenerative retinal disease, numbering 1.5 million in 2008, to accomplish everyday activities. Placed under the existing retina, it directly stimulates the neurons, replacing defective cells. These implants should eventually allow patients to recognize faces, read large print and move independently in a restricted environment. The challenge for the Altran teams was to find solutions to produce artificial retina in series, in order to bring solutions to the widest number of patients. [2]

Pain-treatment based on cell micro-encapsulation

In 1998, the Altran Foundation prize was awarded to the Toulouse-Rangueil University laboratory, and to the Kappa Biotech company [3] for their pain-treatment project based on cell micro-encapsulation. [4] The micro-encapsulation process stops the organism from rejecting these cells by protecting them in a sphere, thus preventing the immune system from recognizing them. The process involves creating biocompatible micro-membranes which are implanted using in-vitro fertilization which is live allogeneic or xenogenic cells that are wrapped in a semi-permeable immune-sparing membrane using a bioengineering technique known as cell encapsulation for therapeutic purposes. Until recently, the implantation posed a number of productivity problems, as it was taking 15 minutes for one micro-membrane to be implanted. Altran teams stepped in to help solve this problem. Their studies demonstrated that the automated implantation option, using a laser optical guidance system, was the most promising approach. With the cooperation of Tarbes E.N.I. students, Altran consultants developed a robot to automate the microcapsule filling operation using a dual-needle system. The robot is now commercialized.[ citation needed ]

Test patch for child food allergies

The team from DBV Technologies [5] has developed a patented innovative process, the E-patch, which is used to determine allergies of children. The ready-to-use standardised patch tests are highly reliable and conserve the allergic agents in their best state of allergy.

This innovative technique uses the principal of freeze drying and electrification to retain the allergic agents on the patch, without using solvent or glue. The E-patch is then conditioned so that it remains air and water tight. Once applied to the child the allergic agents are rapidly hydrated by body transpiration and liberated from the patch. They enter into contact with the skin and create, if positive, a reaction which can be seen by the doctor 48 hours later. [6]

Environmental awards

Economic solar panel

The MAXXUN project was to develop a system of disruptive solar cells based on the luminescent solar concentrating (LSC) technology, in order to lower the investment for a solar energy system by more than half. Altran Technologies consultants have worked during a year with the award-winning team to increase the surface area of the panel from 2.5 cm2 to 10 cm2; to apply an absorbing and dispersing layer on this extra surface area; to optimize light power under different conditions; to build a demonstration model and to identify potential partners. [7]

Ecologic system of soil decontamination

The Altran Foundation jury awarded the first prize 2001 to Julien Troquet, a young research engineer and founder of the start-up company Biobasic Environnement. [8] His project consists in developing a decontamination process for soil using bioremediation. This process allows for a complete decontamination using a gentle "alternative" method, so the excavation of the site is not necessary and the ecosystem is preserved. It is five times less expensive than competing techniques and can also be used on many different types of pollution. [9]

Laser restoration of historical monuments

The companies Jaulard [10] and Trivella (companies from France and Italy respectively), together with the laser specialists Quantel [11] (France) and Unilaser (from France and Portugal) have developed the LAMA project of a laser that can be carried by hand and used to clean the facades and sculpted ornaments of historical monuments. The process makes it easier to select the area to be cleaned without damaging "the outer skin" of the stone and outperforms all other existing systems at a fifth of the cost. [12]

International Solidarity Awards

Desalination of sea water

Work by Viviane Renaudin has led to the development of a new type of multiple-effect plate evaporator, which can be used for the desalination of brackish or sea water. The proposed distillation process is based on the principle of multiple-effect dripping film plate evaporators. The innovation lies in the horizontal transfer of vapour to the condensation zone. From a socio-economic point of view, thanks to its human-scale dimensions, its modular construction and its ease of assembly, the system has the advantage of being usable by unskilled operators in developing countries. The process also has political value: it enables countries to end their dependence on their neighbours for their drinking water supplies. [13]

New generation fuel

The aim of Guy Reinaud's project is to reply to the needs, in renewable domestic energy, of a population of 2 billion individuals living in the tropical regions of Africa, Latin America and Asia, and at the same time fighting against deforestation and climatic changes. The proposed solution is biomass charcoal as a source of renewable energy - patented and developed by Pro-Natura International. Biomass charcoal produces domestic energy from non-upgraded biomass, other than wood, in particular agricultural residues non-consumed by animals. By reducing the dependence on wood, biomass charcoal protects forests and as a consequence fights against desertification. Moreover, the energy produced by biomass charcoal is equal to that of wood charcoal for a sales price per kilo 50% cheaper. [14]

Science Awards

Detection of cosmic particles

HiSPARC, [15] a Dutch university research Institute, is proposing to challenge teams of secondary school pupils and teachers with the study of ultra-high energy cosmic rays. HiSPARC wants to make young people discover and "experience the sciences" by creating a teaching network of teams of pupil-researchers. Liaising closely with academic and scientific institutions, these groups will work on the design, control and operation of particular items of detection equipment. The retrieval of the data obtained and its analysis will then be the subject of interpretation. [16]

Food tracing systems

The first prize went to Dominique Grégoire from the company TechniGREG [17] who developed new tracing systems: TraciLOG and TraciMEAL. This improved monitoring of the cold chain is a major step forward as far as consumer safety is concerned. The principle is to endow each mobile container with "electronic intelligence", thus enabling it to log each of the phases through which it passes, monitor its internal temperature and record information about whether its doors are open or closed. This information is gathered automatically and securely, without any contact with the contents, and requires no human intervention. It is a reliable global management indicator for use by the logistics service in charge of maintaining the cold chain. Altran engineers worked side by side with the prize-winner, on conducting market studies, on the choice of suppliers, at developing product packaging, on the design of an electronic module and on the transition to the production stage for both TraciLOG and TraciMEAL. [18] After the support, TechniGREG increased its capital of more than 1 million euros. The efforts of these teams were rewarded in March 2001, when a fully operational version of TraciLOG was installed for the first time by a supermarket distributor. TraciMEAL was adopted last May by an institutional food service provider in Toulouse. Since then, TechniGREG, which has registered many patents related to this innovation, has come into business with many companies, particularly in the air transport sector.

Notes

  1. NY State Department of Health Archived 2009-10-07 at the Wayback Machine , June 2005
  2. Press Release on the Artificial Retina, October 2nd 2007
  3. "Laboratoire KAPPA BIOTECH (Coordonnees, adresse, produits et medicaments - Labo pharmaceutique et parapharmaceutique)". Archived from the original on 2009-07-24. Retrieved 2009-11-06.
  4. Altran c'est nous !, 1998 : Pain and physical handicap [ permanent dead link ], January 30th 2006
  5. "Home". dbv-technologies.com.
  6. History of DBV Technologies Archived 2009-03-22 at the Wayback Machine , 2007
  7. John M. Grohol, Psych Central, February 21st 2009
  8. "Document sans titre". Archived from the original on 2008-07-05. Retrieved 2009-11-06.
  9. Centrale Santé Archived 2008-08-27 at the Wayback Machine , 2007
  10. "Jaulard". Archived from the original on 2011-02-02. Retrieved 2009-11-06.
  11. "LUMIBIRD- the specialist in laser technologies".
  12. European Commission Research, 1997
  13. JL Martin-Lagardette, Water and Wastes digest, 2009
  14. Pro-Natura International Green Charcoal Archived 2010-07-04 at the Wayback Machine , last updated January 2009
  15. "Home". hisparc.nl.
  16. J.W Van Holten HISPARC A view from the bottom, February 28th 2005
  17. "Technigreg - Home". Archived from the original on 2009-10-01. Retrieved 2009-11-06.
  18. TechniGREG Awards Archived 2008-12-28 at the Wayback Machine , 2001

Related Research Articles

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. The replaced function does not have to be related to life support, but it often is. For example, replacement bones and joints, such as those found in hip replacements, could also be considered artificial organs.

<span class="mw-page-title-main">Wireless power transfer</span> Transmission of electrical energy without wires as a physical link

Wireless power transfer (WPT), wireless power transmission, wireless energy transmission (WET), or electromagnetic power transfer is the transmission of electrical energy without wires as a physical link. In a wireless power transmission system, an electrically powered transmitter device generates a time-varying electromagnetic field that transmits power across space to a receiver device; the receiver device extracts power from the field and supplies it to an electrical load. The technology of wireless power transmission can eliminate the use of the wires and batteries, thereby increasing the mobility, convenience, and safety of an electronic device for all users. Wireless power transfer is useful to power electrical devices where interconnecting wires are inconvenient, hazardous, or are not possible.

<span class="mw-page-title-main">Briquette</span> Compressed block of biomass used for fueling a fire

A briquette is a compressed block of coal dust or other combustible biomass material used for fuel and kindling to start a fire. The term derives from the French word brique, meaning brick.

<span class="mw-page-title-main">Bionics</span> Application of natural systems to technology

Bionics or biologically inspired engineering is the application of biological methods and systems found in nature to the study and design engineering systems and modern technology.

Wilson Greatbatch was an American engineer and pioneering inventor. He held more than 325 patents and was a member of the National Inventors Hall of Fame and a recipient of the Lemelson–MIT Prize and the National Medal of Technology and Innovation (1990).

<span class="mw-page-title-main">Nanorobotics</span> Emerging technology field

Nanoid robotics, or for short, nanorobotics or nanobotics, is an emerging technology field creating machines or robots, which are called nanorobots or simply nanobots, whose components are at or near the scale of a nanometer. More specifically, nanorobotics refers to the nanotechnology engineering discipline of designing and building nanorobots with devices ranging in size from 0.1 to 10 micrometres and constructed of nanoscale or molecular components. The terms nanobot, nanoid, nanite, nanomachine and nanomite have also been used to describe such devices currently under research and development.

Micro combined heat and power, micro-CHP, µCHP or mCHP is an extension of the idea of cogeneration to the single/multi family home or small office building in the range of up to 50 kW. Usual technologies for the production of heat and power in one common process are e.g. internal combustion engines, micro gas turbines, stirling engines or fuel cells.

Neuroprosthetics is a discipline related to neuroscience and biomedical engineering concerned with developing neural prostheses. They are sometimes contrasted with a brain–computer interface, which connects the brain to a computer rather than a device meant to replace missing biological functionality.

Telectronics Pty Ltd was an Australian company best known for its role in developing the pacemaker. It was located in Lane Cove, Sydney. In 1988 the business was acquired by Pacific Dunlop. However, legal claims resulting from the sale of faulty pacemaker electrode leads inherited by the company in acquisition of Cordis Corporation of Miami led to eventual sale of the assets of the company and Pacific Dunlop restructuring itself into Ansell.

<span class="mw-page-title-main">Retinal implant</span>

A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD). Retinal implants are being developed by a number of private companies and research institutions, and three types are in clinical trials: epiretinal, subretinal, and suprachoroidal. The implants introduce visual information into the retina by electrically stimulating the surviving retinal neurons. So far, elicited percepts had rather low resolution, and may be suitable for light perception and recognition of simple objects.

An artificial cell, synthetic cell or minimal cell is an engineered particle that mimics one or many functions of a biological cell. Often, artificial cells are biological or polymeric membranes which enclose biologically active materials. As such, liposomes, polymersomes, nanoparticles, microcapsules and a number of other particles can qualify as artificial cells.

A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s. The idea of using electrical current to provide sight dates back to the 18th century, discussed by Benjamin Franklin, Tiberius Cavallo, and Charles LeRoy.

<span class="mw-page-title-main">Cyborg</span> Being with both organic and biomechatronic body parts

A cyborg —a portmanteau of cybernetic and organism—is a being with both organic and biomechatronic body parts. The term was coined in 1960 by Manfred Clynes and Nathan S. Kline. In contrast to biorobots and androids, the term cyborg applies to a living organism that has restored function or enhanced abilities due to the integration of some artificial component or technology that relies on feedback.

Narec, since 2014 known as the National Renewable Energy Centre, is a part of the Offshore Renewable Energy (ORE) Catapult, a British technology innovation and research centre for offshore wind power, wave energy, tidal energy and low carbon technologies. ORE Catapult's head office is in Glasgow, Scotland. The centre operates multi-purpose offshore renewable energy test and demonstration facilities. It is similar to other centres, such as NREL in the US and National Centre for Renewable Energies (CENER) in Spain. The National Renewable Energy Centre is based in Blyth, Northumberland.

Boston Micromachines Corporation is a US company operating out of Cambridge, Massachusetts. Boston Micromachines manufactures and develops instruments based on MEMS technology to perform open and closed-loop adaptive optics. The technology is applied in astronomy, beam shaping, vision science, retinal imaging, microscopy, laser communications, and national defense. The instruments developed at Boston Micromachines include deformable mirrors, optical modulators, and retinal imaging systems, all of which utilize adaptive optics technology to enable wavefront manipulation capabilities which enhance the quality of the final image.

<span class="mw-page-title-main">Gholam A. Peyman</span> Iranian-American ophthalmologist and retina surgeon known for inventing LASIK eye surgery

Gholam A. Peyman is an Iranian American ophthalmologist, retina surgeon, and inventor. He is best known for his invention of LASIK eye surgery, a vision correction procedure designed to allow people to see clearly without glasses. He was awarded the first US patent for the procedure in 1989.

The European Inventor Award, are presented annually by the European Patent Office, sometimes supported by the respective Presidency of the Council of the European Union and by the European Commission, to inventors who have made a significant contribution to innovation, economy and society, predominantly in Europe. Inventions from all technological fields are considered for this award. The winners in each category are presented with an award shaped like a sail. There is no cash prize associated with the award, however there is a cash prize for all 3 of the Young Inventors Prize finalists.

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

Mark S. Humayun is a Pakistani-American ophthalmologist, engineer, scientist, inventor and academic – the only ophthalmologist elected a member of both U.S. National Academies of Medicine and Engineering. He is a university professor with joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering.

<span class="mw-page-title-main">Robert MacLaren</span> British ophthalmologist

Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.